The INNO-LIPA HBV-DR assay is superior to sequencing for the detection of YMDD-mutants

被引:1
|
作者
Tillmann, H
Wedemeyer, H
Bock, CT
Finger, A
Glomb, I
Magerstest, P
Trautwein, C
Manns, MP
机构
[1] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany
[2] Univ Tubingen, Inst Mol Biol, Tubingen, Germany
关键词
D O I
10.1016/S0168-8278(03)80874-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
608
引用
收藏
页码:176 / 177
页数:2
相关论文
共 48 条
  • [21] Comparison between Direct Sequencing and INNO-LiPA Methods for HPV Detection and Genotyping in Thai Women
    Chinchai, Teeraporn
    Chansaenroj, Jira
    Junyangdikul, Pairoj
    Swangvaree, Sukumarn
    Karalak, Anant
    Niruthisard, Somchai
    Poovorawan, Yong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (04) : 989 - 993
  • [22] Sanger sequencing versus INNO-LiPA® HBV PreCore assay for routine detection of precore and basal core promoter mutations in hepatitis virus B chronically infected patients
    Alidjinou, E. K.
    Bocket, L.
    Pigot, V.
    Lambert, V.
    Hallaert, C.
    Canva, V.
    Hober, D.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 90 (04) : 277 - 279
  • [23] Subtyping analysis of hepatitis C virus using the Inno-LiPA assay and NS5B sequencing
    Gontcharova, V.
    Hebner, C.
    Martin, R.
    Ku, K. S.
    Miller, M. D.
    Mo, H.
    Svarovskaia, E. S.
    ANTIVIRAL THERAPY, 2013, 18 : A136 - A136
  • [24] Validation of the INNO-LiPA HBV DR Assay (Version 2) in Monitoring Hepatitis B Virus-Infected Patients Receiving Nucleoside Analog Treatment
    Niesters, H. G. M.
    Zoulim, F.
    Pichoud, C.
    Buti, M.
    Shapiro, F.
    D'Heuvaert, N.
    Celis, L.
    Doutreloigne, J.
    Sablon, E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (03) : 1283 - 1289
  • [25] Comparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditions
    Aberle, SW
    Kletzmayr, J
    Watschinger, B
    Schmied, B
    Vetter, N
    Puchhammer-Stöckl, E
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (05) : 1972 - 1974
  • [26] The use or accurate measurement of HBV DNA in combination with the INNO-LiPA HBV resistance assay during lamivudine treatment: Implications for disease management.
    Niesters, HGM
    Pas, SD
    Wolters, L
    van Nunen, A
    Fries, E
    de Man, RA
    Osterhaus, AD
    HEPATOLOGY, 2000, 32 (04) : 453A - 453A
  • [27] HBV/4DR 9G test and its comparison with INNO-LiPA HBV multi-DR test for the detection of drug-resistant Hepatitis B virus
    Chantratita, Wasun
    Song, Keum-Soo
    Pongthanapisith, Viroj
    Thongbaiphet, Nipa
    Angkanavin, Kanokwan
    Nimse, Satish Balasaheb
    Sonawane, Mukesh Digambar
    Kim, Taisun
    JOURNAL OF VIROLOGICAL METHODS, 2016, 237 : 58 - 63
  • [28] Evaluation of the INNO-LiPA Rif.TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin
    Rossau, R
    Traore, H
    DeBeenhouwer, H
    Mijs, W
    Jannes, G
    DeRijk, P
    Portaels, F
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) : 2093 - 2098
  • [29] Use of the Novel INNO-LiPA Line Probe Assay for Detection of Hepatitis B Virus Variants That Confer Resistance to Entecavir Therapy
    Jardi, Rosendo
    Rodriguez-Frias, Francisco
    Tabernero, David
    Homs, Maria
    Schaper, Melanie
    Esteban, Rafael
    Buti, Maria
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (02) : 485 - 488
  • [30] HEPATITIS B VIRUS (HBV) REVERSE TRANSCRIPTASE MUTATION IS RARE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB): A PROSPECTIVE MULTICENTER STUDY USING INNO-LIPA HBV DR3 ASSAY
    Nguyen, Mindie H.
    Trinh, Huy N.
    Garcia, Ruel T.
    Nguyen, Huy A.
    Levitt, Brian S.
    Cooper, Allen D.
    Keeffe, Emmet B.
    Khanh Nguyen
    Daugherty, Tami
    Lutchman, Glen A.
    Ayoub, Walid S.
    Ahmed, Aijaz
    Garcia, Gabriel
    da Silveira, Eduardo B.
    HEPATOLOGY, 2011, 54 : 1080A - 1080A